Purpose To report the effectiveness of repeated intravitreal dexamethasone (DEX) inserts in
noninfectious uveitis patients. Design Prospective, single-center, interventional clinical trial …

Uveitis is a type of ocular inflammatory disease caused by various etiologies, for which
corticosteroids are the main treatment. Dexamethasone Intravitreal implant (DEX-I) has been …

Purpose The purpose of this study was to investigate the safety and effectiveness of an
intravitreally injected dexamethasone-containing implant (Ozurdex®) in the treatment of …

Purpose: To investigate dexamethasone intravitreal implant (DEX implant; OZURDEX,
Allergan, Inc) in the treatment of uveitic cystoid macular edema that had persisted in the …

Purpose: To evaluate the real-life efficacy and safety of the intravitreal dexamethasone
implant in uveitis. Methods: This retrospective observational multicentric study included 152 …

Purpose: To assess safety and efficacy of intravitreal dexamethasone (DEX) implant in
refractory uveitic macular edema (ME). Methods: We retrospectively analyzed medical …

Purpose: Investigation of the efficacy of intravitreal dexamethasone implants (0.7 mg) in
patients with Behçet disease (BD) who had cystoid macular edema (CME) despite …

Macular edema (ME) is a common cause of visual loss among eyes with uveitis, and its
management can be challenging. Steroids are an effective treatment for ME, and intravitreal …

Objective To investigate clinical and spectral-domain optical coherence tomography (SD-
OCT) biomarkers correlating with pre-injection visual acuity (VA), post-injection VA, and the …

Purpose To evaluate the efficacy of intravitreal dexamethasone implant (IDI) for the
treatment of persistent diabetic macular edema (DME) in a subgroup of pseudophakic and …